HBIO vs BLFS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

HBIO

44.2
AI Score
VS
HBIO Wins

BLFS

35.2
AI Score

Investment Advisor Scores

HBIO

44score
Recommendation
HOLD

BLFS

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO BLFS Winner
Revenue 43.48M 4.52M HBIO
Net Income -6.33M -2.31M BLFS
Gross Margin 57.2% 45.1% HBIO
Net Margin -14.6% -51.0% HBIO
Operating Income -2.15M -2.13M BLFS
ROE -85.4% -18.2% BLFS
ROA -8.3% -16.2% HBIO
Total Assets 76.29M 14.25M HBIO
Cash 6.50M 3.28M HBIO
Current Ratio 1.87 15.41 BLFS
Free Cash Flow -1.45M -2.71M HBIO

Relative Price Performance (Last 90 Days)

HBIO 1M: +20.8% · 3M: +35.5% BLFS 1M: +20.6% · 3M: +50.0%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71

RSI (14): 71.1 · Price: $7.48

BLFS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.8% over 20 days), RSI 78

RSI (14): 78.2 · Price: $37.10

Fundamentals Snapshot

Metric HBIO BLFS
Market Cap
Forward P/E 11.6 112.4
Trailing P/E 37.0
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.1%
EPS -2.30 1.00
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.